Subscribe for great stories in your community!
Following the positive clinical testing results from a combination cancer therapy developed by Incyte and Merck, Incyte is looking to raise $666.6 million to…
A new study combining the use of Merck’s Keytruda cancer treatment with Incyte’s immune-oncology drug Epacadostat, is showing promising results in advanced…
Before we send you to this site, please subscribe to our daily newsletter.